PILOT TRIAL OF AN ADJUVANT PENTAVALENT VACCINE FOR PATIENTS WITH SMALL CELL LUNG CANCER (SCLC)

被引：0
|
作者：
Krug, Lee M. [1 ]
Varghese, Anna [1 ]
Ragupathi, Govind [2 ]
George, Constantine [2 ]
Sawada, Ritsuko [3 ]
Scholz, Wolfgang W. [3 ]
Hansen, David [3 ]
Livingston, Philip O. [3 ]
Delasos, Lukas [1 ]
Pietanza, Maria C. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Thorac Oncol Serv, Dept Med, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] Mabvax Therapeut, San Diego, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
small cell lung cancer; vaccine; immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.13-007
引用
收藏
页码：S1231 / S1232
页数：2
相关论文
共 50 条
  • [1] Therapeutic approaches for patients with small cell lung cancer (SCLC)
    Spelda, S
    Kaplanová, J
    Skricková, J
    Dusek, L
    Svobodník, A
    Dolezal, L
    LUNG CANCER: CURRENT TOPICS, 2001, : 215 - 218
  • [2] Surgery for small cell lung cancer (SCLC), where are the patients?
    Montes, A.
    de Lobel, N.
    Sawicka, L.
    LUNG CANCER, 2010, 67 : S11 - S12
  • [3] Phase II trial of amrubicin in patients with previously treated small cell lung cancer (SCLC).
    Kato, T.
    Nokihara, H.
    Ohe, Y.
    Yamamoto, N.
    Sekine, I.
    Kunitoh, H.
    Kubota, K.
    Nishiwaki, Y.
    Saijo, N.
    Tamura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 379S - 379S
  • [4] RADIOTHERAPY PLUS ADJUVANT CHEMOTHERAPY FOR LIMITED SMALL CELL LUNG-CANCER (SCLC)
    FRYTAK, S
    EAGAN, RT
    LEE, RE
    CARR, DT
    COLES, DT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 349 - 349
  • [5] TREATMENT DURATION IN SMALL CELL LUNG-CANCER (SCLC) - A RANDOMIZED TRIAL
    SOUHAMI, R
    EARL, H
    ASH, C
    SPIRO, S
    GEDDES, D
    HARPER, P
    TOBIAS, J
    QUINN, H
    BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 899 - 900
  • [6] Why are patients with small cell lung cancer (SCLC) not given chemotherapy?
    Khan, M. I.
    Brown, E. J.
    Lord, H.
    Allan, C.
    Sim, L.
    Buckle, F.
    Rankin, E. M.
    LUNG CANCER, 2012, 75 : S59 - S59
  • [7] Treatment of small cell lung cancer (SCLC) in elderly patients (EP)
    Paccagnella, A
    Favaretto, A
    Tomio, L
    Morabito, A
    Oniga, F
    DePoli, F
    Sartore, F
    Fiorentino, MV
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 82 - 82
  • [8] PROGNOSTIC FACTORS IN PATIENTS WITH SMALL CELL LUNG-CANCER (SCLC)
    EARL, HM
    SOUHAMI, RL
    ASH, CM
    SPIRO, SG
    GEDDES, D
    HARPER, PG
    TOBIAS, JS
    BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 897 - 897
  • [9] Pilot Study on the Tumor Immune Microenvironment Between Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)
    Zhang, W.
    Yuan, X.
    Wang, X.
    Huang, S.
    Tu, J.
    Liu, F.
    Li, J.
    Li, J.
    Chen, Y.
    Chu, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S132 - S132
  • [10] Compliance with oral topotecan in patients with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
    Eckardt, J. R.
    Ramlau, R.
    Gervais, R.
    Shepherd, F.
    O'Brien, M.
    Ciuleanu, T.
    Dharan, B.
    Wissel, P.
    Ross, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 387S - 387S
12345